cagrisema semaglutide cagrilintide phase 3 results 2024 2025 RESEARCH ARTICLE: Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1 @SubodhVermaMD https://www.ahajournals.org/doi/full/10.1161/HYPERTENSIONAHA.125.26055 Novo Nordisk's experimental obesity drug
Description
Abrupt discontinuation followed by immediate full-dose initiation of a new medication increases side effect risk and may cause a temporary rebound in appetite and weight
The other 60% eventually either commit to chronic treatment or accept higher weight
[DOI] [PubMed] [Google Scholar] 46.Yun SP, et al
The weight loss program through semaglutide or tirzepatide injections at Atlanta Face & Body is a bit different than other med spa environments
